S

Soleno Therapeutics
D

SLNO

59.170
USD
1.19
(2.05%)
مغلق
حجم التداول
58,154
الربح لكل سهم
-1
العائد الربحي
-
P/E
-14
حجم السوق
3,144,590,183
أصول ذات صلة الأخبار المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.